SEC Form 4 · accession 0001144204-18-014217

PHIBRO ANIMAL HEALTH CORP · PAHC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Exec. VP, Corporate Strategy · Director

Period of report

Mar 8, 2018

Accepted (ET)

Mar 12, 2018 · 9:11 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001069899

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Class A Common Stock	Mar 8, 2018	M	3,425	$11.83	A	3,425	D
Class A Common Stock	Mar 8, 2018	S	3,425	$40.00	D	0	D
Class A Common Stock	Mar 9, 2018	M	6,576	$11.83	A	6,576	D
Class A Common Stock^F2	Mar 9, 2018	S	6,576	$40.03	D	0	D
Class A Common Stock	Mar 12, 2018	M	13,162	$11.83	A	13,162	D
Class A Common Stock	Mar 12, 2018	S	13,162	$40.00	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option to purchase Common Stock	$11.83	Mar 8, 2018	M	3,425	D	Mar 1, 2012	Feb 28, 2019	Class A Common Stock	3,425	19,738	D
Option to purchase Common Stock	$11.83	Mar 9, 2018	M	6,576	D	Mar 1, 2012	Feb 28, 2019	Class A Common Stock	6,576	13,162	D
Option to purchase Common Stock	$11.83	Mar 12, 2018	M	13,162	D	Mar 1, 2012	Feb 28, 2019	Class A Common Stock	13,162	0	D

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.10, inclusive.